مقایسهٔ روش‌ها

	مرور جامع انطباقی با PRISMA	بازبینی مبتنی بر PRISMA
حوزه	علم‌سنجی	علم‌سنجی
خانواده	Process / pipeline	Process / pipeline
سال پیدایش	2015 (umbrella review methodology); 2022 (PRIOR reporting extension)	2009 (original PRISMA statement); updated 2020
پدیدآور	Aromataris et al. (JBI); PRIOR reporting extension by Fusar-Poli et al.	David Moher and PRISMA Group
نوع	Evidence synthesis / review of systematic reviews	Structured reporting framework for systematic reviews
منبع بنیادین	Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015). Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach. International Journal of Evidence-Based Healthcare, 13(3), 132–140.	Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71.
نام‌های دیگر	umbrella review with PRISMA, PRIOR-guided umbrella review, overview of reviews, PRISMA umbrella overview	PRISMA review, PRISMA-guided systematic review, PRISMA 2020 review, PRISMA-compliant review
مرتبط	5	5
خلاصه	A PRISMA-compliant umbrella review is a structured synthesis of existing systematic reviews and meta-analyses on a topic, conducted and reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines — specifically the PRIOR extension developed for umbrella reviews. By operating one level above primary research, it maps the totality of evidence, identifies convergent or contradictory findings across reviews, and quantifies evidence strength at the highest tier of the evidence hierarchy.	A PRISMA-based review is a systematic literature review conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Originally published by Moher et al. in 2009 and updated as PRISMA 2020 by Page et al., the framework specifies a 27-item checklist and a four-phase flow diagram covering identification, screening, eligibility, and inclusion — ensuring full transparency and reproducibility in the review process.